Sep, 13 2017 14:25 JST

Source: Eisai

Eisai to Launch New "Etak Antimicrobial Spray Alpha" Containing Long-Acting Antimicrobial Agent Etak

The Answer to Viruses and Bacteria in the Home! Eliminates Viruses & Bacteria, Antimicrobial Action that Lasts for 1 Week

TOKYO, Sep, 13 2017 - (JCN Newswire) - Eisai Co., Ltd. will launch Etak Antimicrobial Spray Alpha (classified as miscellaneous goods), which contains long-acting antimicrobial agent Etak, on September 19 (Tuesday). This product eliminates viruses and bacteria with an antimicrobial action that lasts for one week.

Etak, the main ingredient used in the product, is a long-acting antimicrobial agent developed by Professor Hiroki Nikawa of the Department of Oral Health Engineering at Hiroshima University's Graduate School of Biomedical and Health Sciences. An adhesive component in Etak chemically binds the antimicrobial component to the spray area, providing an antimicrobial effect that lasts for one week.

In the home, there are many surfaces and items, such as doorknobs, bannisters, tables, flooring, and toys, to which viruses and bacteria can spread easily when touched. This product is an answer to the needs of consumers who wish to keep those viruses and bacteria at bay. We suggest habitually using Etak Antimicrobial Spray Alpha to eliminate viruses and bacteria in the home. Additionally, this product contains no alcohol and is both scentless and colorless, making it ideal for use on a wide variety of surfaces and items in the home.

Eisai is also marketing Etak Antimicrobial Spray, an alcohol type spray for mouth masks which uses the same long-acting antimicrobial agent Etak. By spraying it on a mouth mask prior to use, you can prevent viruses and bacteria from collecting on the mask for 24 hours.

Eisai remains committed to ensuring the delivery of products that satisfy the diversified needs of consumers and to making further contributions to increase the benefits provided to them.

Product Outline

1. Product Name: Etak Antimicrobial Spray Alpha (Miscellaneous Goods)

2. Ingredients: Water, long-acting antimicrobial agent (compound containing ethoxysilane), solubilizing agent, stabilizing agent

3. Directions for use:
- Please remove stopper when using. Returning the stopper locks the product.
- Please keep the nozzle 20-30cm away from the target and spray an appropriate amount.
- When using for the first time, please press the spray button a few times to activate the spray mechanism.
- In order to achieve a uniform spread, please wipe the surface with a cloth or other item after spraying.
- Please do not use this product upside down.

4. Volume / Suggested retail price (excluding tax): 250ml / 1,280 yen

5. Manufacturer: Jex Co., Ltd.

6. Supplier: Eisai Co., Ltd.

http://www.acnnewswire.com/topimg/Low_EisaiEtak.jpg
Product Photograph

About long-acting antimicrobial agent Etak

Etak was developed by Professor Hiroki Nikawa of the Department of Oral Health Engineering at Hiroshima University's Graduate School of Biomedical and Health Sciences. It is a patented longacting antimicrobial agent (patent number: 4830075) that combines quaternary ammonium salts, which are also included in hand sanitizers and oral cleansing agents used by dentists, with a silane analogue, an immobilizing agent that functions as adhesive. When a quaternary ammonium salt is sprayed onto an object, it would normally lose its antimicrobial properties upon drying. However, with Etak, the adhesive component chemically binds the antimicrobial component to the spray area, thereby preserving the antimicrobial effect.


About Eisai
Eisai Co., Ltd. (TSE:4523; ADR:ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.


Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120
Source: Eisai
Sectors: HealthCare

Copyright ©2017 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Multimedia


Etak Antimicrobial Spray Alpha
 

Related Press Release


New Data From Long-Term Extension of Phase 1B Study of Investigational Alzheimer's Disease Treatment Aducanumab Presented at 10th Clinical Trials on Alzheimer's Disease
November 06 2017 19:37 JST
 
Eisai's New Drug Application of Anticancer Agent Lenvatinib for Hepatocellular Carcinoma Accepted in China
October 31 2017 12:05 JST
 
Eisai to Present Latest Data at 10th Clinical Trials on Alzheimer's Diesase
October 31 2017 10:27 JST
 
Biogen and Eisai Expand Existing Collaboration Agreement to Develop and Commercialize Investigational Alzheimer's Disease Treatments Including Phase 3 Aducanumab
October 24 2017 10:08 JST
 
Eisai: Transfer of Rights to Anti-Rheumatic Agent Kolbet Tablets 25mg in Japan
October 13 2017 09:48 JST
 
Small and Easy to Take, Just One Tablet per Dose Eisai to Launch "Onji-No-Megumi" for Improving Forgetfulness in Middle Age and Beyond
October 11 2017 11:48 JST
 
Eisai and Biotoscana Sign Exclusive Licensing Agreement for Latin America
October 04 2017 09:49 JST
 
Sato Pharmaceutical and Eisai to Co-Promote New Oral Antifungal Agent Containing Active Ingredient Fosravuconazole in Japan
October 03 2017 14:11 JST
 
Eisai Presents Results of Phase Iii Trial of Lenvima (Lenvatinib) in Unresectable Hepatocellular Carcinoma in Oral Session at 20th CSCO Annual Meeting
September 29 2017 15:12 JST
 
Eisai: Application for Additional Indication of Lenvima for Hepatocellular Carcinoma Accepted for Review by U.S. FDA
September 27 2017 12:25 JST
 
More Press release >>

Latest Press Release


More Latest Release >>